Quick-Med Technologies, Inc. Appoints New Director
Richard F. Caffrey, president of R. F. Caffrey & Associates, Inc., appointed to Quick-Med Technologies Inc.Â’s Board of Directors
Gainesville, FL (PRWEB) March 17, 2004
Quick-Med Technologies, Inc. (OTC Bulletin Board: QMDT) (the “Company”), a life sciences company specializing in the development of proprietary, broad-based technologies in the consumer, healthcare, and industrial markets, today announced that Richard F. Caffrey has been appointed to its Board of Directors, effective as of March 8th, 2004.
Mr. Caffrey has more than twenty years of corporate experience, including marketing research, strategic planning, business development and management recruiting, in both senior-line and senior-staff positions. Mr. Caffrey is currently the president of R. F. Caffrey & Associates, Inc., a full service marketing consulting practice that offers assistance to participants in the healthcare, industrial, and consumer related markets. Previously, Mr. Caffrey was vice president of John R. Starr, Inc., a management consulting firm; president, and chief operating officer of CPM Inc., a New England based specialty paper company; vice president of sales and marketing of Codman & Shurtleff, Inc. (subsidiary of Johnson & Johnson Company), a surgical instruments and equipment company; group product director of Surgikos, Inc. (subsidiary of Johnson & Johnson Company), a marketer of medical products and supplies; vice president, business development of Chicopee (subsidiary of Polymer Group, Inc. whose major holdings are controlled by InterTech Group), a non-woven fabrics supplier; and marketing research manager of Sealtest Foods. He holds both B. S. and M. B.A. degrees in Business Administration from Seton Hall University.
“Richard Caffrey will bring deep strategic and corporate planning experience to our Company,” said Michael R. Granito, chairman of Quick-Med Technologies, Inc. “He will bring new perspectives and expertise to the board and play an important role in implementing Quick-Med Technologies’ business strategy in North America.”
“Quick-Med Technologies is an impressive company and I am delighted to join its board. I look forward to working towards further enhancing the penetration of the Company’s MultiStat™ and NIMBUS™ technologies and contributing to the development of its businesses,” said Richard Caffrey.
About Quick-Med Technologies, Inc.
Quick-Med Technologies is a life sciences company focused on developing proprietary, broad-based technologies for consumer, industrial, and healthcare use, as well as for advanced military and civilian medical applications. The Company’s two core products under development are (1) MultiStat™, a family of advanced compounds shown to be effective in broad-based skin therapy applications, and (2) NIMBUS™, a family of advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer preservatives. Quick-Med Technologies is listed under the symbol “QMDT” on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies’ website: http://www. quickmedtech. com (http://www. quickmedtech. com) or email: info@quickmedtech. com
Certain statements in this press release constitute “forward-looking statements”. Such forward-looking statements involve known and unknown risks, certainties and other factors, which may cause the actual results, performance of achievements of Quick-Med Technologies, Inc. (the “Company”) to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. The Company’s future operating results are dependent upon many factors, including whether the Company will ever successfully launch its potential technologies and/or products and the risk factors contained in its periodic and other filings, which are available for review at www. sec. gov. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events, or circumstances after the date of such statement.
